NewGenIvf Group Depreciation & Amortization Growth & History (NIVF)
NewGenIvf Group's depreciation and amortization was $188,109 for fiscal 2025.
View full NewGenIvf Group company overviewNewGenIvf Group annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $188,109 | $168,607 | +864.56% |
| 2024 | 2024-12-31 | $19,502 | −$11,671 | −37.44% |
| 2023 | 2023-12-31 | $31,173 | −$69,360 | −68.99% |
| 2022 | 2022-12-31 | $100,533 | −$66,176 | −39.70% |
| 2021 | 2021-12-31 | $166,709 | — | — |
NewGenIvf Group depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, NewGenIvf Group's depreciation and amortization increased from $166,709 to $188,109, a change of $21,400.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NewGenIvf Group source filings ↗